L Rotenberg

Honeywell (France)

Papers

1

Total Citations

41

H-Index

1

About

Dr. L. Rotenberg is a leading clinical researcher in radiation oncology, with a primary focus on the technical precision and safety of stereotactic body radiation therapy (SBRT). Their most cited work, a 2019 study on the safety and efficacy of fiducial marker implantation for robotic SBRT with fiducial tracking, has garnered 41 citations, establishing a key reference in the field. This seminal paper demonstrated the feasibility and low toxicity of using implanted markers to guide CyberKnife® treatments for extracranial tumors, directly improving the accuracy of tumor targeting while sparing healthy tissue. By validating this technique, Dr. Rotenberg’s research has helped expand the clinical application of robotic radiosurgery, enabling safer treatment for complex, moving tumors. Their work is particularly notable for its rigorous, single-centre observational design, which provided real-world evidence that has influenced clinical protocols and patient outcomes. Dr. Rotenberg’s contributions continue to shape modern radiation therapy, offering students and researchers a model for integrating technological innovation with patient safety.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Honeywell (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago